SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Introgen Therapeutics
An SI Board Since February 2004
Posts SubjectMarks Bans Symbol
802 21 0 INGN
Emcee:  tuck Type:  Unmoderated
Will INGN be the first successful gene therapy company -- at least in oncology? Discuss it's prospects, programs, and competitors here.

corporate-ir.net

A reasonably accurate summary of the company's programs -- from a slightly less biased perspective -- can be seen here and in the following post:

Message 19296970
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
802Yes, It was fun to trade INGN, albeit not as much as some others. <g> AndJibacoa5/20/2011
801Well, apparently somebody is buying INGN shares today in Germany,IGU.F :) RAGJibacoa6/22/2010
800<i>Where are Zeta and Bernard?</i> <b>INGN Files for BankruptDewDiligence_on_SI12/4/2008
799Well, INGN is up 23% with volume now > 2x its ADV. :>) bigcharts.marketwaJibacoa10/29/2008
798Elizabeth, I had not noticed some of the last few postings.<g> I think tJibacoa10/6/2008
797Oh and yes this exchange is also being reported to SI Admin....zeta19619/4/2008
796Yo Dew..stay classy..even the the most rabid far-right 28%ers over at the BO boazeta19619/4/2008
795Yes, I saw that news early this morning.<g> The stock had been on a persiJibacoa9/2/2008
794Shorts have upper hand because they are simply right, Bernard: Message 24901947tuck9/2/2008
793If you read this board, you can't say you weren’t warned about this scam.DewDiligence_on_SI9/2/2008
792INGN Is trying to move some today in anticipation of next week's presentatioJibacoa7/17/2008
791Besides David Nance, Max Talbott and Robert Sobol, other clinicians not directlJibacoa7/11/2008
790There are a few summaries of the CC on Dew's thread, including this extract,tom pope7/11/2008
789Well, the CC with the Q&A, was longer than I thought, but in general it turnJibacoa7/11/2008
788From INGN CC today: <i>“Once Advexin is approved, blah, blah, blah… We fDewDiligence_on_SI7/10/2008
787Will see if the CC tomorrow will help or not the stock, which needs to close aboJibacoa7/9/2008
786Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXtnsaf7/7/2008
785My goodness..the application happened..Bernard, I lost hope here..I really did..zeta19616/30/2008
784The stock opened with an UG after the news, but it is now trying to close it &amJibacoa6/30/2008
783[Evaluation of Functional p53 Biomarker Profiles Predicts Efficacy of Adenoviraltuck5/30/2008
782>>Correction to Press Release Dated May 28, 2008: ADVEXIN(R) Improves Survtuck5/30/2008
781I tried what you’re trying some time ago––to no avail. People believe what they DewDiligence_on_SI5/29/2008
780<b> FROM MARY CROWKEY CANCER RESEARCH CENTERS GROUNDBREAKING CLINICAL TRJibacoa5/29/2008
779<b>From the University of Texas M.D. Anderson Center:</b> News ReleJibacoa5/29/2008
778To see the presentation by Dr. John J. Nemunaitis, this is the link: library.coJibacoa5/29/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):